title: Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate.
abstract: Shigellosis is the leading cause of childhood mortality and morbidity. Despite many years of extensive research a practical vaccine is not yet available against the disease. Recent studies illustrate that bacterial outer membrane proteins are budding target as vaccine antigen. Outer membrane proteins A (OmpA) are among the most immunodominant antigens in the outer membrane of gram negative bacteria and possess many characteristics desired of a vaccine candidate. We observe that OmpA of Shigella flexneri 2a is crossreactive and common antigen among Shigella spp. and the epitope is widely exposed on the cell surface as well as capable of evoking protective immunity in mice. The protective immunity involves participation of both the humoral and cellular immune responses, since OmpA boosts rapid induction of IgG and IgA in both the systemic and mucosal compartments and also activates Th1 cells. The immunopotentiating activity of OmpA is mediated by its ability to bind and stimulate macrophages and up-regulate the surface expression of MHCII, CD80 and CD40, leading to activation of CD4(+) T cells to secrete cytokines and express chemokine receptor and IL-12Rβ2, thereby orchestrating the bridge between innate and adaptive immune responses. This ability is dependent on Toll-like receptor 2 (TLR2), as demonstrated by lack of response by TLR2 knockdown macrophages to OmpA. Hence this property of OmpA to link innate and adaptive immunity via TLR2 offers a novel vista to develop vaccine against shigellosis.
authors.affiliation: Division of Pathophysiology, National Institute of Cholera and Enteric Diseases, P-33, C.I.T. Road, Scheme-XM, Beliaghata, Kolkata 700010, West Bengal, India.
authors.forename: Debasis
authors.initials: D
authors.lastname: Pore
authors.forename: Manoj K
authors.initials: MK
authors.lastname: Chakrabarti
mesh_terms: D056704:Adaptive Immunity; D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology*; D001428:Bacterial Vaccines / Q000276:immunology*; D056738:Cross Protection; D004405:Dysentery, Bacillary / Q000517:prevention & control*; D007111:Immunity, Cellular; D056724:Immunity, Humoral; D007113:Immunity, Innate; D051379:Mice; D012763:Shigella flexneri / Q000276:immunology*; D051195:Toll-Like Receptor 2 / Q000276:immunology
chemical_list: D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D051195:Toll-Like Receptor 2; C078167:OMPA outer membrane proteins
keywords: CD4+ T cells; Macrophages; Outer membrane protein A; Shigella flexneri 2a; Toll-like receptors; Vaccine